Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Greaves, Ronda / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter

IMPACT FACTOR 2018: 3.638

CiteScore 2018: 2.44

SCImago Journal Rank (SJR) 2018: 1.191
Source Normalized Impact per Paper (SNIP) 2018: 1.205

See all formats and pricing
More options …
Volume 57, Issue 6


The biological variation of plasma proenkephalin: data from a stable heart failure cohort

Alan H.B. Wu
  • Corresponding author
  • Department of Laboratory Medicine, University of California, Zuckerberg San Francisco General Hospital, 1001 Potrero Ave., San Francisco, CA 94110, USA
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Inder Anand
  • University of Minnesota, Minneapolis and VA Medical Centers, Minneapolis and San Diego, CA, USA
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2018-10-17 | DOI: https://doi.org/10.1515/cclm-2018-0876


  • 1.

    Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, et al. Proenkephalin expression and encephalin release are widely observed in non-neuronal tissues. Peptides 2006;277:1835–40.Google Scholar

  • 2.

    Beunders R, Struck J, Wu AH, Zarbock A, Di Somma S, Mehta RL, et al. Proenkephalin (PENK) as a novel biomarker for kidney function. J Appl Lab Med 2017;2:400–12.CrossrefGoogle Scholar

  • 3.

    Latini R, Masson S, Anand I, Judd D, Maggioni AP, Chiang YT, et al. Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symnptomatic chronic heart failure. The Valsartan Heart Failure Trial (Val-HeFT). Circulation 2002;106:2454–8.CrossrefPubMedGoogle Scholar

  • 4.

    Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press, 2001.Google Scholar

  • 5.

    Keevil BG, Kilpatrick ES, Nichols SP, Mawlow PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998;44:1535–9.PubMedGoogle Scholar

  • 6.

    Carter JL, Parker CT, Stevens PE, Eaglestone G, Knight S, Farmer CK, et al. Biological variation of plasma and urinary markers of acute kidney injury in patients with chronic kidney disease. Clin Chem 2016;62:876–83.Web of ScienceCrossrefPubMedGoogle Scholar

  • 7.

    Levey AS, Bosch JP, Lewis JB, Green T, Rogers N, Roth D, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999;130:461–70.PubMedCrossrefGoogle Scholar

  • 8.

    Shah KS, Taub P, Patel M, Rehfeldt M, Struck J, Clopton P, et al. Proenkephalin predicts acute kidney injury in cardiac surgery patients. Clin Nephrol 2015;831:29–35.Web of ScienceGoogle Scholar

  • 9.

    Caironi P, Latini R, Struck J, Hartmann O, Bergmann A, Bellato V, et al. Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock. Clin Chem 2018;64:1361–9.CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Corresponding author: Alan H.B. Wu, PhD, Department of Laboratory Medicine, University of California, Zuckerberg San Francisco General Hospital, 1001 Potrero Ave., San Francisco, CA 94110, USA

Received: 2018-08-14

Accepted: 2018-09-21

Published Online: 2018-10-17

Published in Print: 2019-05-27

Author contributions: Research idea and study design: AHW and IA; data acquisition: IA; data analysis/interpretation: AHW and IA; statistical analysis: AHW; supervision or mentorship: NA. Support: none. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: None.

Employment or leadership: The authors disclose that they are members of the Scientific Advisory Board for Sphingotec Inc.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 57, Issue 6, Pages e105–e107, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2018-0876.

Export Citation

©2019 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in